AI Signal & Stock Analysis · Weak ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for EXEL is Weak ↓; the stock is at $51.12 (+1.00% today); neutral (RSI 41); technical trend is down-trend; news sentiment is positive.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Weak ↓ |
|---|---|
| Price | $51.12 |
| Change today | +1.00% |
| RSI (14) | 40.87 |
| Relative volume | 0.37 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $12.7B |
| Forward P/E | 12.76 |
| 52-week high | -11.3% away |
| 52-week low | +51.4% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Positive |
| Sector | Healthcare-Biotech |
| Next earnings | 8/5/2026 4:30:00 PM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns EXEL (Exelixis Inc) a Weak signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
EXEL's RSI is neutral (RSI 41). A reading above 70 is typically considered overbought and below 30 oversold.
EXEL is trading about 11% below its 52-week high and 51% above its 52-week low as of Aug 14 2026, 1:04 PM.
EXEL's next earnings date is 8/5/2026 4:30:00 PM.
EXEL is classified under Healthcare-Biotech in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.